AV
BIIB icon

ASR Vermogensbeheer’s Biogen BIIB Stock Holding History

ASR Vermogensbeheer’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.5M Buy
39,360
+38,760
+6,460% +$7.41M 0.09% 216
2026
Q1 		$110K Buy
+600
New +$111K ﹤0.01% 528
2025
Q2 		– Sell
-1,590
Closed -$218K – 558
2025
Q1 		$218K Buy
+1,590
New +$227K ﹤0.01% 554

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ASR Vermogensbeheer's BIIB Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Biogen (BIIB) stake by 6,460% in Q2 2026, buying an estimated $7.41M and bringing the position to 39,360 shares worth $8.5M. The position accounts for 0.09% of the portfolio, ranked #216.

ASR Vermogensbeheer first reported a position in BIIB in Q1 2025 and has held it in 3 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • ASR Vermogensbeheer held 39,360 shares of Biogen worth $8.5M as of Q2 2026.
  • ASR Vermogensbeheer bought 38,760 Biogen shares in Q2 2026, an estimated $7.41M.
  • Biogen made up 0.09% of ASR Vermogensbeheer's portfolio in Q2 2026, its #216 holding.
  • ASR Vermogensbeheer first reported a position in Biogen in Q1 2025 and has held it in 3 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.